Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Huang W-T, Chen RT, Cassard C. Comment on “Serially combining epidemiological designs does not improve overall signal detection in vaccine safety surveillance.” Drug Saf. 2024. https://doi.org/10.1007/s40264-024-01410-y.
2. Arshad F, Schuemie MJ, Bu F, Minty EP, Alshammari TM, Lai LY, et al. Serially combining epidemiological designs does not improve overall signal detection in vaccine safety surveillance. Drug Saf. 2023;46:797–807.
3. Lai LY, Arshad F, Areia C, Alshammari TM, Alghoul H, Casajust P, et al. Current approaches to vaccine safety using observational data: a rationale for the EUMAEUS (evaluating use of methods for adverse events under surveillance-for vaccines) study design. Front Pharmacol. 2022;13: 837632.
4. Schuemie MJ, Arshad F, Pratt N, Nyberg F, Alshammari TM, Hripcsak G, et al. Vaccine safety surveillance using routinely collected healthcare data: an empirical evaluation of epidemiological designs. Front Pharmacol. 2022;13(893484):2532.
5. Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;8(10):2251–7.